Advertisement

The Scientist

» clinical trials

Most Recent

image: BioTime Seeks Geron Stem Cell Assets

BioTime Seeks Geron Stem Cell Assets

By | November 13, 2012

Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.

1 Comment

image: Setback for Malaria Vaccine

Setback for Malaria Vaccine

By | November 9, 2012

The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.

0 Comments

image: Can Magnesium Magnify Brain Power?

Can Magnesium Magnify Brain Power?

By | October 29, 2012

A magnesium supplement thought to improve brain functioning gets a small clinical trial.

0 Comments

image: Beware of Striking Medical Studies

Beware of Striking Medical Studies

By | October 25, 2012

A large-scale statistical analysis shows that medical studies revealing “very large effects” seldom stand up when other researchers try to replicate them.

0 Comments

image: More Questions About IV Drug

More Questions About IV Drug

By | October 18, 2012

Another clinical trial raises concerns about the efficacy and safety of a common intravenous treatment for patients that have lost large amounts of blood.

0 Comments

image: Uncloaking Clinical Trials

Uncloaking Clinical Trials

By | October 17, 2012

Glaxo­SmithKline will share long-sought, raw trial data—but access will be tightly controlled.  

0 Comments

image: Cantley Changes Jobs

Cantley Changes Jobs

By | September 14, 2012

Renowned cancer researcher Lewis Cantley is leaving Harvard to lead a new cancer center at Weill Cornell Medical College and NewYork-Presbyterian Hospital.

0 Comments

image: Scientists

Scientists "Spin" Results

By | September 13, 2012

A new study of the scientific literature finds that researchers are guilty of overemphasizing the benefits of medical treatments.

0 Comments

image: Fears over Fast-Tracking Drugs

Fears over Fast-Tracking Drugs

By | September 10, 2012

Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.

0 Comments

image: FDA to Debate Starch Treatment

FDA to Debate Starch Treatment

By | August 31, 2012

The US Food and Drug Administration will consider whether or not to stop the use of intravenous starch solutions to replace lost blood.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Ingenuity Systems
Ingenuity Systems
Advertisement